Nesina Articles
FDA approves three Takeda diabetes drugs; expands use of Novartis' Gleevec and Pfizer's Prevnar 13
28 January 2013
Most surveyed physicians in Europe expect to increase Rxing of GLP-1 analogues and DPP-IV inhibitors
18 August 2011
Takeda files US NDA for combo hypertension drug; gets new indications for Nesina in Japan
25 February 2011
Takeda receives pricing approval of Nesina in Japan, triggering milestone for Furiex Pharma
14 June 2010
Japan’s Takeda gets five new products approved on home market, and partner Amgen reveals strong results with Vectibix
19 April 2010
Showing 1-5 of 5 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
